Table 2.

Posttransplant outcomes

	CB	No CB
Median follow-up	21.6 months	11.6 months
Posttransplant relapse	10 (27.8%)	3 (15.8%)
Posttransplant CNS failure	1 (2.8%)	2 (10.5%)
Median overall survival	25.1 months	19.3 months
Median survival in population with prior CNS disease	38.7 months	29.8 months
Median survival in population with relapse as transplant indication	20.1 months	19.3 months
Population still alive	19 (52.8%)	6 (31.5%)
Population that died from complications of transplant	GVHD 3 (8.3%)	GVHD 5 (26.3%)
	Infection 4 (11.1%)	Infection 4 (21.1%)

CB, cranial boost; CNS, central nervous system; GVHD, graft versus host disease.